The Latest Breaking News from Cardlytics

Cardlytics shares have been on a wild ride this March. Should investors follow suit with massive insider buying, or steer clear of this highly volatile small-cap stock?

Former Cardlytics CMO joins Innovid to drive the ad platform’s global marketing efforts

Upgrades

Pulled from Benzinga Pro data, Cardlytics (NASDAQ:CDLX) posted Q1 earnings of $33.04 million, an increase from Q4 of 379.16%. Sales dropped to $67.93 million, a 24.57% decrease between quarters.

Cardlytics (NASDAQ:CDLX) reported its Q1 earnings results on Monday, May 2, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by 30.91%, reporting an EPS of $-0.38 versus an estimate of $-0.55.

Cardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Cardlytics will report an earnings per share (EPS) of $-0.55.

According to Benzinga Pro data, during Q4, Cardlytics (NASDAQ:CDLX) posted sales of $90.05 million. Earnings were up 73.42%, but Cardlytics still reported an overall loss of $11.84 million.

Analysts reiterated a Buy on Cardlytics Inc (NASDAQ:CDLX) post Q4 results. Craig-Hallum analyst Jason Kreyer lowered the firm's price target on Cardlytics from $100 to $70 (15% upside) and kept a Buy. The analyst notes quarterly results were strong despite lingering concerns over the supply chain, labor shortages, and omicron issues faced in the quarter. …

Cardlytics (NASDAQ:CDLX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by 64.29%, reporting an EPS of $-0.15 versus an estimate of $-0.42.